Yes-Associated Protein 1 Inhibition Induces Immunogenic Cell Death and Synergizes with Radiation and PD-1 Blockade (vol 116, pg 894, 2023)

被引:0
|
作者
Zhuang, Yuan [1 ]
Wang, Yuzi [1 ,2 ]
Liu, Chang [1 ]
Li, Sihan [1 ]
Du, Shuyan [3 ]
Li, Guang [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China
[2] Univ Tsukuba, Proton Med Res Ctr, Tsukuba, Japan
[3] China Med Univ, Hosp 1, Dept Cent Lab, Shenyang, Peoples R China
关键词
D O I
10.1016/j.ijrobp.2024.02.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1032 / 1033
页数:2
相关论文
共 50 条
  • [31] Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)
    Matthew J. Hadfield
    Howard Safran
    Marco A. Purbhoo
    Joseph E. Grossman
    Jennifer S. Buell
    Benedito A. Carneiro
    Oncogene, 2024, 43 : 758 - 762
  • [32] Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)
    Hadfield, Matthew J.
    Safran, Howard
    Purbhoo, Marco A.
    Grossman, Joseph E.
    Buell, Jennifer S.
    Carneiro, Benedito A.
    ONCOGENE, 2024, 43 (10) : 758 - 762
  • [33] Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma
    Hsu, Ping-Chih
    Miao, Jinbai
    Wang, Yu-Cheng
    Zhang, Wen-Qian
    Yang, Yi-Lin
    Wang, Chih-Wei
    Yang, Cheng-Ta
    Huang, Zhen
    You, Joanna
    Xu, Zhidong
    Jablons, David M.
    You, Liang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (06) : 3139 - 3148
  • [34] Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade
    Kofla, G.
    Radecke, C.
    Frentsch, M.
    Walther, W.
    Stintzing, S.
    Riess, H.
    Bullinger, L.
    Na, I-K
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [36] Diffusing Alpha-Emitters Radiation Therapy Promotes a Proimmunogenic Tumor Microenvironment and Synergizes With Programmed Cell Death Protein 1 Blockade
    Del Mare, Sara
    Nishri, Yossi
    Shai, Amit
    Efrati, Margalit
    Deutsch, Lisa
    Den, Robert B.
    Kelson, Itzhak
    Keisari, Yona
    Domankevich, Vered
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (03): : 707 - 718
  • [37] Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma (vol 25, pg 936, 2019)
    Ribas, Antoni
    Lawrence, Donald
    Atkinson, Victoria
    Agarwal, Sachin
    Miller, Wilson H., Jr.
    Carlino, Matteo S.
    Fisher, Rosalie
    Long, Georgina V.
    Hodi, F. Stephen
    Tsoi, Jennifer
    Grasso, Catherine S.
    Mookerjee, Bijoyesh
    Zhao, Qing
    Ghori, Razi
    Moreno, Blanca Homet
    Ibrahim, Nageatte
    Hamid, Omid
    NATURE MEDICINE, 2019, 25 (08) : 1319 - 1319
  • [38] HIV-1 Vpr potently induces programmed cell death in the CNS in vivo (vol 26, pg 116, 2007)
    Cheng, Xiaodong
    DNA AND CELL BIOLOGY, 2007, 26 (03) : 192 - 192
  • [39] PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer (vol 220, e20220729, 2023)
    Ali, Lestat R.
    Garrido-Castro, Ana C.
    Lenehan, Patrick J.
    Bollenrucher, Naima
    Stump, Courtney T.
    Dougan, Michael
    Goel, Shom
    Shapiro, Geoffrey I.
    Tolaney, Sara M.
    Dougan, Stephanie K.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 220 (09):
  • [40] Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade
    Holzgruber, Julia
    Martins, Christina
    Kulcsar, Zsofi
    Duplaine, Alexandra
    Rasbach, Erik
    Migayron, Laure
    Singh, Praveen
    Statham, Edith
    Landsberg, Jennifer
    Boniface, Katia
    Seneschal, Julien
    Hoetzenecker, Wolfram
    Berdan, Emma L.
    Sui, Shannan Ho
    Ramsey, Matthew R.
    Barthel, Steven R.
    Schatton, Tobias
    NATURE COMMUNICATIONS, 2024, 15 (01)